Interim Results
Financial highlights
· Revenue increased 10.5% to £417.2m (H1 2013: £377.5m) with growth delivered in all payor categories
· In-patient and daycase discharge volumes up 9.2% on prior year to approximately 128,000
· Adjusted EBITDA* up 9.3% to £79.9m (H1 2013: £73.1m)
· Operating profit before exceptional items, up 7.9% to £57.3m (H1 2013: £53.1m)
· Operating cash flow of £71.0m, with 88.9% cash conversion of EBITDA (H1 2013: 37.9%)
· Pro-forma adjusted earnings per share at 8.43p per share **
· Investment in acquisitions and capital investments totalled £71.9m, including St Anthony's Hospital acquisition
· Capital restructuring on IPO reduced pro-forma net debt to £467.4m
Operational highlights
· Acquisition of St Anthony's Hospital completed, pending Competition and Markets Authority ('CMA') clearance
· Bristol radiotherapy centre opened in April 2014 and reached EBITDA breakeven within two months of opening
· Cardiac catheterisation lab in Cardiff completed
· Increased in-patient and daycase volumes improved capacity utilisation by 4% to 64%
· Work ongoing on two additional theatre developments for delivery in H2 2014